Ajanta Pharma posts Rs 84-crore consolidated profit in Q1FY 2015-16
EBITDA grew 26 per cent at Rs 123 crore
Ajanta Pharma has reported today its performance for the first quarter ended June 30,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Ajanta Pharma
Ajanta Pharma gets approvals for three ANDAs
Montelukast tablets are indicated for the treatment of prophylaxis and chronic treatment of asthma and to relieve symptoms of…
Ajanta Pharma posts Q4 FY ’15 results
Standalone Q4 revenue has shown a growth of 19 per cent and PAT growth of 20 per cent
Ajanta Pharma has posted its performance…
Ajanta Pharma posts standalone and third quarter results
Board of Directors has approved sub-division of nominal value of equity shares of the company from Rs 5 each to nominal value of…